(S (NP (NP (ADJP (RB Molecularly) (VBN targeted)) (NN contrast) (VBN enhanced) (IN ultrasound)) (PRN (-LRB- -LRB-) (NP (NN mCEUS)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT a) (ADJP (RB clinically) (JJ promising)) (NN approach)) (PP (IN for) (NP (NP (JJ early) (NN cancer) (NN detection)) (PP (IN through) (NP (NP (VBN targeted) (NN imaging)) (PP (IN of) (NP (NNP VEGFR2) (PRN (-LRB- -LRB-) (NNP KDR) (-RRB- -RRB-)) (NNS receptors))))))))) (. .))
(S (NP (PRP We)) (VP (VBP have) (VP (VBN developed) (NP (NP (JJ computational) (NN enhancement) (NNS techniques)) (PP (IN for) (NP (NN mCEUS))) (VP (VBN tailored) (S (VP (TO to) (VP (VB address) (NP (NP (DT the) (JJ unique) (NNS challenges)) (PP (IN of) (NP (NP (VBG imaging) (NN contrast) (NN accumulation)) (PP (IN in) (NP (NNS humans))))))))))))) (. .))
(S (NP (DT These) (NNS techniques)) (VP (VBP utilize) (NP (JJ dynamic) (NN analysis)) (S (VP (TO to) (VP (VB distinguish) (NP (ADJP (RB molecularly) (VBN bound)) (NN contrast) (NN agent)) (PP (IN from) (NP (JJ other) (JJ contrast-mode) (NN signal) (NNS sources)))))) (, ,) (S (VP (VBG enabling) (S (NP (NP (NN analysis)) (PP (IN of) (NP (NN contrast) (NN agent) (NN accumulation)))) (VP (TO to) (VP (VB be) (VP (VBN performed) (PP (IN during) (NP (NP (NN contrast) (NN bolus) (NN arrival)) (SBAR (WHADVP (WRB when)) (S (NP (NP (DT the) (NN signal)) (ADJP (JJ due) (PP (TO to) (NP (JJ molecular) (NN binding))))) (VP (VBZ is) (ADJP (JJS strongest)))))))))))))) (. .))
(S (S (VP (VBN Applied) (PP (TO to) (NP (NP (DT the) (CD 18) (JJ human) (JJ patient) (NNS examinations)) (PP (IN of) (NP (DT the) (JJ first-in-human) (JJ molecular) (NN ultrasound) (NN breast) (NN lesion) (NN study))))))) (, ,) (NP (JJ computational) (NN enhancement)) (VP (VBD improved) (NP (DT the) (NN ability) (S (VP (TO to) (VB differentiate) (PP (IN between) (NP (NP (JJ pathology-proven) (NN lesion)) (CC and) (NP (JJ pathology-proven) (JJ normal) (NN tissue)))) (PP (IN in) (NP (NP (JJ real-world) (JJ human) (NN examination) (NNS conditions)) (SBAR (WHNP (WDT that)) (S (VP (VBD involved) (NP (DT both) (NN patient) (CC and) (NN probe) (NN motion)))))))))) (, ,) (PP (IN with) (NP (NP (NNS improvements)) (PP (IN in) (NP (NN contrast) (NN ratio))) (PP (IN between) (NP (NP (NN lesion)) (CC and) (NP (JJ normal) (NN tissue)))) (SBAR (WHNP (IN that)) (S (PP (IN in) (NP (JJS most) (NNS cases))) (VP (VBP exceed) (NP (NP (NP (DT an) (NN order)) (PP (IN of) (NP (NN magnitude)))) (PRN (-LRB- -LRB-) (NP (CD 10x)) (-RRB- -RRB-))))))))) (. .))
(S (ADVP (RB Notably)) (, ,) (NP (JJ computational) (NN enhancement)) (VP (VBD eliminated) (NP (NP (DT a) (JJ false) (JJ positive) (NN result)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (NN tissue) (NN leakage) (NN signal)) (VP (VBD was) (VP (VBN misinterpreted) (PP (IN by) (NP (NNS radiologists))) (S (VP (TO to) (VP (VB be) (NP (JJ contrast) (JJ agent) (NN accumulation))))))))))) (. .))
